Poster Abstract Session:
222. Antibiotic Stewardship: Diagnostics
Saturday, October 29, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

.

Tracks: Epidemiology and Infection Control, Adult ID

Presentations:
The Impact of Molecular Testing on Antibiotic Utilization in Community-acquired Pneumonia
Stephen Blatt, MD ; Aleksandr Yultyev, MD ; Miao Huang, MD ; Jenni Steinbrunner, BS
Multiplex Respiratory Viral Panel Use In The Intensive Care Unit And Its Effect On Antibiotic Usage And Patient Outcomes.
Cory Hussain, MBBS ; Joan-Miquel Balada-Llasat, Pharm D, PhD ; Preeti Pancholi, PhD ; Kurt Stevenson, MD, MPH, FSHEA
Implementation of a Procalcitonin-Guided Antimicrobial Use in Intensive Care Unit Patients with Sepsis: A Cost-Effectiveness Analysis Utilizing Real-World Experiences
Curtis Collins, PharmD, MS ; Kara Brockhaus, PharmD ; Taeyong Sim, MD ; Anupam Suneja, MD ; Anurag Malani, MD, FIDSA
Clinical utility of Verigene® for antibiotic intervention in ICU and non-ICU patient populations
Abigail Rhoades, Pharm.D. ; Siyun Liao, Pharm.D., PhD, BCPS ; Jessica Winter, Pharm.D., BCPS ; Christopher Droege, Pharm.D. ; Madeline Foertsch, Pharm.D., BCPS ; Eric Mueller, Pharm.D., FCCM
The Impact of a Rapid Diagnostic for Bloodstream Infections Without Antimicrobial Stewardship Intervention
Timothy Baures, MD ; Kim Hanson, MD, MHS ; Amanda Breviu, MD ; Richard E. Nelson, PhD ; Mckenzie Carlisle, PhD ; Emily Spivak, MD
Posters
  • IDSAPoster_10_18_16_ES.pdf (374.7 kB)
  • Molecular Diagnostics Can Lead To Early Optimization of Antimicrobial Therapy For Staphylococcal Bacteremia: Experience at a Large Tertiary-Care VA Medical Center
    Kelly Rudd, PharmD ; Sharanie Sims, Pharm.D., BCPS (AQ-ID) ; Brigid Wilson, PhD ; Amy Hirsch, Pharm.D., BCPS ; Federico Perez, MD ; Usha Stiefel, M.D.
    Do Clinical Pharmacists Intervention with Procalcitonin (PCT) Levels Change Antibiotic Therapy in an Academic and Level One Trauma Center: Pilot Study
    Karen Nguyen, PharmD ; Eva Sullivan, PharmD ; Jennifer Lee, PharmD ; Harminder Sikand, PharmD, FCSHP, FASHP
    Role of Respiratory Virus Panels in Antimicrobial Stewardship in Immunocompromised Patients
    Nicholas Mercuro, PharmD ; Rachel M Kenney, PharmD ; Robert Tibbetts, Ph.D. D(ABMM), F(CCM) ; Linoj Samuel, PhD., D(ABMM) ; Susan L Davis, PharmD
    Posters
  • Mercuro_Biofire_IDWeek2016.pdf (298.3 kB)
  • Distribution and clinical predictors of time to positivity (TTP) of blood cultures (BC): tools for a shorter duration of empirical antimicrobial therapy for suspected sepsis
    Merel Lambregts, MD ; Sandra Bernards, MD, PhD ; Martha Van Der Beek, MD, PhD ; Leo Visser, MD PhD ; Mark G.J. De Boer, MD PhD
    Posters
  • posterlambregts.pdf (586.4 kB)
  • Optimal Use of Procalcitonin for Antimicrobial Stewardship
    Sara Nelson, MD ; Kimberly Boeser, PharmD, BCPS AQ-ID ; Gretchen Sieger, MS ; Lei Zhang, MS ; Steven Dittes, MD ; Patricia Ferrieri, MD, FIDSA ; Nishant Sahni, MD ; Emily Medcraft, PharmD, BCPS ; Michelle Borchart, PharmD, BCPS ; Ronald Greenberg, PharmD, BCPS ; Susan Kline, MD, MPH, FSHEA
    Impact of rapid identification of positive blood cultures by Verigene system on antibiotic prescription: prospective study of community-onset bacteremia in a tertiary hospital in Japan
    Kayoko Hayakawa, M.D., Ph.D. ; Kazuhisa Mezaki, M. T. ; Kei Yamamoto, M.D. ; Yoshikazu Mutoh, M.D ; Motoyuki Tsuboi, M.D. ; Takehiro Hashimoto, M.D. ; Yuichi Katanami, M.D. ; Satoshi Kutsuna, M.D., Ph.D. ; Nozomi Takeshita, M.D., Ph.D. ; Masao Kobayakawa, MD ; Norio Ohmagari, M.D., M.Sc., Ph.D.
    Assessing the Impact of an Automatic Antimicrobial Stewardship Review of Positive Blood Cultures in Patients with Gram-Negative or Gram-Positive Bloodstream Infections
    Tracy P. Trang, PharmD, BCPS ; Alexandra Hilts-Horeczko, PharmD ; Sarah B. Doernberg, MD, MAS ; Conan Macdougall, PharmD, MAS, BCPS
    Evaluation of the impact of positive blood culture results over holidays
    Motoyuki Tsuboi, M.D. ; Kayoko Hayakawa, M.D., Ph.D. ; Kazuhisa Mezaki, M. T. ; Yuichi Katanami, M.D. ; Kei Yamamoto, M.D. ; Satoshi Kutsuna, M.D., Ph.D. ; Nozomi Takeshita, M.D., Ph.D. ; Norio Ohmagari, M.D., M.Sc., Ph.D.
    Utilizing Nanosphere's Verigene® Technology to Assist with Possible Rapid Pharmacologic De-escalation of Antimicrobial Therapy In A University Hospital Setting
    Elizabeth Cady, PharmD ; W. Cliff Rutter, PharmD ; Donna R. Burgess, RPh ; Scott Kincaid, PharmD ; Craig Martin, PharmD, MBA ; David S. Burgess, PharmD, FCCP
    Characterization of Clinical Improvements After Implementation of New Blood Culture Strategy for Severe Sepsis Patients
    Patti Fidelman, BS, MS, MT(ASCP) ; Kayleigh Rygalski, B.S. ; Julie Riley, BS, MT(ASCP)SM ; Diana Hernandez, Ph.D. ; Donna Wolk, MHA, Ph.D., D(ABMM)
    Posters
  • Wolk IDWeek Final 10262016.pdf (444.0 kB)
  • Clinical and Pharmaco-economical Impact of Rapid Diagnostic Technology and Antimicrobial Stewardship For Patients With Gram Positive and Gram Negative Bloodstream Infections
    Nikunj Vyas, PharmD ; Matthew Gogoj, PharmD ; Cindy Hou, DO, FACOI ; Tanvi Patel, RPh ; Deborah Cunningham, MT HHS, BA
    Clinical Impact of Rapid Molecular Diagnosis of Bloodstream Infections at an Academic Medical Center in New York City
    Matthew S. Simon, MD, MS ; Angela Loo, PharmD BCPS (AQ-ID) ; Michael Satlin, MD ; Harjot Singh, MD ScM ; Christina Chai, MD ; Horatio Holzer, MD ; John Dillon, BA ; Naveen Galla, BA ; Linda Gerber, PhD ; Zhengming Chen, PhD ; Audrey Schuetz, MD ; Stephen Jenkins, PhD ; David P. Calfee, MD, MS, FIDSA, FSHEA
    Impact of Respiratory Viral Panel Polymerase Chain Reaction (RVP-PCR) Assay Turnaround Time on Length of Stay and Antibiotic Use in Patients with Respiratory Viral Illnesses
    Sebastian Choi, PharmD ; Rubiya Kabir, PharmD, BCPS ; Pranisha Gautam-Goyal, MD ; Prashant Malhotra, MBBS, FACP, FIDSA
    Clinical outcomes of a MALDI-TOF-tied antimicrobial stewardship intervention compared to MALDI-TOF reporting without intervention: a quasi-experimental study
    Maressa Santarossa, PharmD ; Susan C. Bleasdale, MD ; Amanda Harrington, PhD, D(ABMM) ; Scott T. Benken, PharmD, BCPS-AQ CV ; Maria C. Merrick, DO ; Daniel S Murrell, MD ; Ellen Stolar, MD ; Amber Williams, PharmD Candidate ; Alan E. Gross, PharmD, BCPS-AQ ID
    Familiarity and Utilization of Rapid Diagnostic Technologies for Antimicrobial Stewardship
    Monica V. Mahoney, PharmD, BCPS-AQ ID ; Christopher Bland, PharmD, BCPS, FIDSA ; Kristi Kuper, PharmD, BCPS ; P. Brandon Bookstaver, PharmD, FCCP, BCPS, AAHIVP
    Collaboration between an Antimicrobial Stewardship Team and the Microbiology Laboratory can shorten time to Directed Antibiotic Therapy
    Tanaya Bhowmick, MD ; Frances Hetherington, MD ; Navaneeth Narayanan, PharmD ; Julia Cornett, MD ; Vincent Mcauliffe, MD ; Thomas Kirn, MD, PhD ; Melvin Weinstein, MD
    Targeted antimicrobial stewardship intervention for inpatients with viral respiratory tract infections
    Christopher F. Lowe, MD, FRCPC ; Michael Payne, MD, FRCPC ; Allison Kirkwood, BSc(Pharm), ACPR, MHA ; Mark Hull, MD ; Victor Leung, MD, FRCPC

    CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.